JP2023524668A5 - - Google Patents

Info

Publication number
JP2023524668A5
JP2023524668A5 JP2022565551A JP2022565551A JP2023524668A5 JP 2023524668 A5 JP2023524668 A5 JP 2023524668A5 JP 2022565551 A JP2022565551 A JP 2022565551A JP 2022565551 A JP2022565551 A JP 2022565551A JP 2023524668 A5 JP2023524668 A5 JP 2023524668A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
jia
composition according
tnf antibody
pediatric patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022565551A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023524668A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/053429 external-priority patent/WO2021220140A1/en
Publication of JP2023524668A publication Critical patent/JP2023524668A/ja
Publication of JP2023524668A5 publication Critical patent/JP2023524668A5/ja
Pending legal-status Critical Current

Links

JP2022565551A 2020-04-27 2021-04-26 若年性特発性関節炎を治療するための材料及び方法 Pending JP2023524668A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063015902P 2020-04-27 2020-04-27
US202063015894P 2020-04-27 2020-04-27
US202063015889P 2020-04-27 2020-04-27
US63/015,889 2020-04-27
US63/015,894 2020-04-27
US63/015,902 2020-04-27
PCT/IB2021/053429 WO2021220140A1 (en) 2020-04-27 2021-04-26 Materials and methods for treating juvenile idiopathic arthritis

Publications (2)

Publication Number Publication Date
JP2023524668A JP2023524668A (ja) 2023-06-13
JP2023524668A5 true JP2023524668A5 (enExample) 2024-05-01

Family

ID=78336251

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022565551A Pending JP2023524668A (ja) 2020-04-27 2021-04-26 若年性特発性関節炎を治療するための材料及び方法

Country Status (9)

Country Link
EP (1) EP4143226A4 (enExample)
JP (1) JP2023524668A (enExample)
KR (1) KR20230005284A (enExample)
CN (1) CN115461365A (enExample)
AU (1) AU2021263136A1 (enExample)
BR (1) BR112022021766A2 (enExample)
CA (1) CA3127807A1 (enExample)
IL (1) IL297623A (enExample)
MX (1) MX2022013502A (enExample)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ595225A (en) * 2005-05-16 2013-05-31 Abbott Biotech Ltd Use of tnf inhibitor for treatment of erosive polyarthritis
US10465003B2 (en) * 2016-02-05 2019-11-05 Janssen Biotech, Inc. Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes
WO2018140121A1 (en) * 2017-01-30 2018-08-02 Janssen Biotech, Inc. Anti-tnf antibodies, compositions, and methods for the treatment of active psoriatic arthritis

Similar Documents

Publication Publication Date Title
Steere et al. Treatment of the early manifestations of Lyme disease
Krain et al. Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid
JP2024170522A5 (enExample)
KLINE et al. Further studies on: one day treatment of depression with 5-Htp
US20070161566A1 (en) Method of treating multiple sclerosis
JP2000514091A (ja) 心筋症の処置
CN105228622B (zh) 用于治疗多发性硬化的PPARγ激动剂
JPH06100446A (ja) (S)−α−フルオロメチル−ヒスチジン及びそのエステルを使用するぜん息の治療方法
WO1993018761A1 (en) Pharmaceutical compositions and methods using isobutyramide for treating betaglobin disorders
JPH0776179B2 (ja) 免疫学的因子を含む病気の治療用組成物
JPS63502591A (ja) リユ−マチ様関節炎の治療のための方法と物質
US4887995A (en) Method of treating sickle cell anemia
JP2024531314A5 (enExample)
JP2022514152A5 (enExample)
JP4272885B2 (ja) コカイン依存症治療用薬剤
JP2022514561A5 (enExample)
JP2023524668A5 (enExample)
JP2022536279A5 (enExample)
JP2023538065A5 (enExample)
JP2023544620A5 (enExample)
US10610592B2 (en) Treatment of multiple sclerosis
JP2022518208A5 (enExample)
JP2025521501A5 (enExample)
CN1282241A (zh) 局部麻醉剂抗血管性头痛的新用途
JP2022526493A5 (enExample)